Ambrx Biopharma Inc. AMAM
28.00 +28.00
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|
| 7.40M | 7.46M | 13.67M | 10.31M | |
| 7.40M | 7.46M | 13.67M | 10.31M | |
| 7.40M | 7.46M | 13.67M | 10.31M | |
| 83.80M | 71.88M | 26.79M | 32.78M | |
| 53.31M | 54.30M | 20.43M | 26.38M | |
| 20.84M | 17.07M | 6.35M | 6.40M | |
| -76.40M | -64.42M | -13.12M | -22.47M | |
| 968.00K | 0 | 0 | 0 | |
| 1.94M | 1.00K | 1.00K | -2.00K | |
| -78.00M | -68.08M | -16.54M | -20.06M | |
| -78.00M | -68.08M | -16.54M | -20.06M | |
| -78.00M | -68.08M | -16.54M | -20.06M | |
| -78.00M | -68.29M | -17.84M | -22.31M | |
| -2.03 | -3.36 | -0.98 | -1.05 | |
| -2.03 | -3.36 | -0.98 | -1.05 | |
| -2.03 | -3.36 | -0.98 | -1.05 | |
| -75.09M | -68.08M | -16.54M | -20.06M | |
| -75.09M | -68.08M | -16.54M | -20.06M | |
| 38.61M | 20.45M | 16.53M | 19.44M | |
| 38.61M | 20.45M | 16.53M | 19.44M |